Inhibitory effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats

Br J Anaesth. 1999 Dec;83(6):945-7. doi: 10.1093/bja/83.6.945.

Abstract

We have investigated the effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats using microdialysis. Twenty-one male Wistar rats weighing 200-300 g were allocated randomly to one of four groups: i.p. injection of ketamine 100 mg kg-1 with clonidine 0 (saline: group C0, n = 6), 3 (group C3, n = 5), 30 (group C30, n = 5) and 300 micrograms kg-1 (group C300, n = 5). As reported previously, ketamine increases norepinephrine release. In groups C0 and C3, marked increases in norepinephrine release were observed with maximum values of mean 483 (SEM 55)% and 412 (53)% compared with basal values, respectively. Although significant increases in norepinephrine release were also observed (276 (43)%) in group C30, they were significantly lower than those in groups C0 and C3 (P < 0.01 and P < 0.05, respectively). In group C300, there was a significant reduction in norepinephrine release (62 (13)%) compared with basal and the three other groups (P < 0.01). This inhibitory effect of clonidine on norepinephrine may be related to reduction in undesirable emergence reactions after ketamine anaesthesia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Anesthetics, Intravenous
  • Animals
  • Central Nervous System / drug effects
  • Clonidine / pharmacology*
  • Ketamine / pharmacology*
  • Male
  • Norepinephrine / metabolism*
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / metabolism
  • Rats

Substances

  • Adrenergic alpha-Agonists
  • Anesthetics, Intravenous
  • Ketamine
  • Clonidine
  • Norepinephrine